Short-term Outcomes of Water Vapor Therapy (Rezum) for BPH/LUTS
in the First Czech Cohort

J 2021

Short-term Outcomes of Water Vapor Therapy (Rezum) for BPH/LUTS in the First Czech Cohort

WASSERBAUER, Roman, Dalibor PACIK, Gabriel VARGA, Vítězslav VÍT, Jiří JARKOVSKÝ et. al.

Basic information

Original name

Short-term Outcomes of Water Vapor Therapy (Rezum) for BPH/LUTS in the First Czech Cohort

Authors

WASSERBAUER, Roman (203 Czech Republic, belonging to the institution), Dalibor PACIK (203 Czech Republic), Gabriel VARGA (703 Slovakia, belonging to the institution), Vítězslav VÍT (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Michal FEDORKO (703 Slovakia, belonging to the institution)

Edition

UROLOGY JOURNAL, TEHRAN, UROL & NEPHROL RES CTR-UNRC, 2021, 1735-1308

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30217 Urology and nephrology

Country of publisher

Islamic Republic of Iran

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 1.555

RIV identification code

RIV/00216224:14110/21:00124058

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.22037/uj.v18i.6843

UT WoS

000747743200004

Keywords in English

benign prostatic hyperplasia; lower urinary tract symptoms; minimally invasive treatment; vapor; water

Abstract

V originále

Purpose: To evaluate the short-term results of water vapor therapy (RezUm) for BPH/LUTS in the first cohort of Czech patients. Materials and methods: Patients with BPH and moderate to severe LUTS (N = 76) who underwent RezUm treatment from December 2019 to July 2020 were included in the prospective study. Prior to the procedure, they completed the IPSS and OABv8 questionnaires and underwent uroflowmetry, transrectal ultrasound of the prostate, and PSA sampling. The parameters before and 3 months after the procedure were compared and statistically evaluated. Results: The study protocol was completed by 92% of patients (N = 70). We observed a significant increase in Qmax (median 17.7 vs. 8.8 mL/s, P < .001), Qave (9 vs. 4.5 mL/s, P = .001) and voided volume (241 vs. 171 mL, P < .001) and a significant reduction in post-void residual (average 17.5 vs. 67.7 mL), prostate volume (39.3 vs. 62.3 mL) and total PSA (median 1.9 vs. 2.5 ng/mL, resp. P values < .001). There was also a significant decrease in OABv8 score (average 7.6 vs. 16.6, P < .001) and IPSS QoL (1.6 vs. 4.0, P = .037). The improvement in the IPSS score was apparent, yet statistically insignificant (6.8 vs. 16, P = .079). Conclusion: Water vapor therapy is an effective and safe method of BPH/LUTS treatment in the short-term.

Citovat

WASSERBAUER, Roman, Dalibor PACIK, Gabriel VARGA, Vítězslav VÍT, Jiří JARKOVSKÝ and Michal FEDORKO. Short-term Outcomes of Water Vapor Therapy (Rezum) for BPH/LUTS in the First Czech Cohort. UROLOGY JOURNAL. TEHRAN: UROL & NEPHROL RES CTR-UNRC, 2021, vol. 18, No 6, p. 699-702. ISSN 1735-1308. Available from: https://dx.doi.org/10.22037/uj.v18i.6843.

@article{1831960,
   author = {Wasserbauer, Roman and Pacik, Dalibor and Varga, Gabriel and Vít, Vítězslav and Jarkovský, Jiří and Fedorko, Michal},
   article_location = {TEHRAN},
   article_number = {6},
   doi = {http://dx.doi.org/10.22037/uj.v18i.6843},
   keywords = {benign prostatic hyperplasia; lower urinary tract symptoms; minimally invasive treatment; vapor; water},
   language = {eng},
   issn = {1735-1308},
   journal = {UROLOGY JOURNAL},
   title = {Short-term Outcomes of Water Vapor Therapy (Rezum) for BPH/LUTS in the First Czech Cohort},
   url = {https://journals.sbmu.ac.ir/urolj/index.php/uj/article/view/6843},
   volume = {18},
   year = {2021}
}

TY  - JOUR
ID  - 1831960
AU  - Wasserbauer, Roman - Pacik, Dalibor - Varga, Gabriel - Vít, Vítězslav - Jarkovský, Jiří - Fedorko, Michal
PY  - 2021
TI  - Short-term Outcomes of Water Vapor Therapy (Rezum) for BPH/LUTS in the First Czech Cohort
JF  - UROLOGY JOURNAL
VL  - 18
IS  - 6
SP  - 699-702
EP  - 699-702
PB  - UROL & NEPHROL RES CTR-UNRC
SN  - 17351308
KW  - benign prostatic hyperplasia
KW  - lower urinary tract symptoms
KW  - minimally invasive treatment
KW  - vapor
KW  - water
UR  - https://journals.sbmu.ac.ir/urolj/index.php/uj/article/view/6843
N2  - Purpose: To evaluate the short-term results of water vapor therapy (RezUm) for BPH/LUTS in the first cohort of Czech patients. Materials and methods: Patients with BPH and moderate to severe LUTS (N = 76) who underwent RezUm treatment from December 2019 to July 2020 were included in the prospective study. Prior to the procedure, they completed the IPSS and OABv8 questionnaires and underwent uroflowmetry, transrectal ultrasound of the prostate, and PSA sampling. The parameters before and 3 months after the procedure were compared and statistically evaluated. Results: The study protocol was completed by 92% of patients (N = 70). We observed a significant increase in Qmax (median 17.7 vs. 8.8 mL/s, P < .001), Qave (9 vs. 4.5 mL/s, P = .001) and voided volume (241 vs. 171 mL, P < .001) and a significant reduction in post-void residual (average 17.5 vs. 67.7 mL), prostate volume (39.3 vs. 62.3 mL) and total PSA (median 1.9 vs. 2.5 ng/mL, resp. P values < .001). There was also a significant decrease in OABv8 score (average 7.6 vs. 16.6, P < .001) and IPSS QoL (1.6 vs. 4.0, P = .037). The improvement in the IPSS score was apparent, yet statistically insignificant (6.8 vs. 16, P = .079). Conclusion: Water vapor therapy is an effective and safe method of BPH/LUTS treatment in the short-term.
ER  -

WASSERBAUER, Roman, Dalibor PACIK, Gabriel VARGA, Vítězslav VÍT, Jiří JARKOVSKÝ and Michal FEDORKO. Short-term Outcomes of Water Vapor Therapy (Rezum) for BPH/LUTS in the First Czech Cohort. \textit{UROLOGY JOURNAL}. TEHRAN: UROL \&{} NEPHROL RES CTR-UNRC, 2021, vol.~18, No~6, p.~699-702. ISSN~1735-1308. Available from: https://dx.doi.org/10.22037/uj.v18i.6843.

Detailed Information on Publication Record